| Name | Title | Contact Details |
|---|
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
NorthStar® Medical Radioisotopes is a nuclear medicine technology company dedicated to transforming the ways that medical radioisotopes are produced and distributed around the world.
Advanced Care Scripts is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ultimed is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
On the Forefront of COVID-19 Recognized leader in the COVID-19 field by governmental and non-governmental organizations as the reference assay...